Literature DB >> 12142172

Platelets and cancer.

G F Nash1, L F Turner, M F Scully, A K Kakkar.   

Abstract

The presence of platelets in association with cancer deposits has been recognised for over 100 years; however, the recognition of a two-way interaction has been more recent. The link between cancer spread and platelet stimulation is pivotal to understanding of the hypercoagulable state found in most cancer patients. The assistance of platelets in cancer spread may provide opportunities to interrupt this relation, thus inhibiting metastasis.

Entities:  

Mesh：

Year:  2002        PMID： 12142172     DOI： 10.1016/s1470-2045(02)00789-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


  104 in total

Review 1.  The emerging molecular machinery and therapeutic targets of metastasis.

Authors:  Yutong Sun; Li Ma
Journal:  Trends Pharmacol Sci       Date:  2015-05-01       Impact factor: 14.819

2.  Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential.

Authors:  Radu Minea; Corey Helchowski; Barbara Rubino; Kyle Brodmann; Stephen Swenson; Francis Markland
Journal:  Toxicon       Date:  2011-02-24       Impact factor: 3.033

3.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 4.  Platelets and metastasis revisited: a novel fatty link.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 5.  Novel therapy for liver regeneration by increasing the number of platelets.

Authors:  Kazuhiro Takahashi; Soichiro Murata; Nobuhiro Ohkohchi
Journal:  Surg Today       Date:  2012-11-21       Impact factor: 2.549

6.  Platelet count and the risk for thrombosis and death in the elderly.

Authors:  J G van der Bom; S R Heckbert; T Lumley; C E Holmes; M Cushman; A R Folsom; F R Rosendaal; B M Psaty
Journal:  J Thromb Haemost       Date:  2008-12-20       Impact factor: 5.824

7.  Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

Authors:  C E Holmes; J E Levis; D L Ornstein
Journal:  Clin Exp Metastasis       Date:  2009-05-15       Impact factor: 5.150

8.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.

Authors:  Chris E Holmes; Maria E Ramos-Nino; Benjamin Littenberg
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

10.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.